Plasma and memory B-cell kinetics in infants following a primary schedule of CRM197-conjugated serogroup C meningococcal polysaccharide vaccine

Immunology

Volumn 127, Issue 1, 2009, Pages 134-143

  Kelly, Dominic F ^a   Snape, Matthew D ^a   Perrett, Kirsten P ^a   Clutterbuck, Elizabeth A ^a   Lewis, Susan ^a   Rohner, Geraldine Blanchard ^a   Jones, Meryl ^a   Yu, Ly Mee ^a   Pollard, Andrew J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibody; B cell; Infant; Memory; Meningococcal; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G; INACTIVATED VACCINE; MENINGOCOCCUS VACCINE; PEDIACEL; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BACTERIAL MENINGITIS; CLINICAL TRIAL; DIPHTHERIA; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; NEISSERIA MENINGITIDIS; PLASMA CELL; PRIORITY JOURNAL; TREATMENT RESPONSE;

B-LYMPHOCYTES; BACTERIAL PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION SCHEDULE; IMMUNOLOGIC MEMORY; INFANT; MALE; MENINGOCOCCAL VACCINES; VACCINES, CONJUGATE;

EID: 63849167605     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02934.x     Document Type: Article

References (55)

1. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007 357 : 1903 15.
2. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003 171 : 4969 73.
3. Kelly DF, Pollard AJ, Moxon ER. Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. Jama 2005 294 : 3019 23.
4. Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J 2004 23 (12 Suppl S274 9.
5. MacLennan JM, Shackley F, Heath PT et al. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial. Jama 2000 283 : 2795 801.
6. Richmond P, Borrow R, Miller E et al. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis 1999 179 : 1569 72.
7. Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004 364 : 365 7.
8. Snape MD, Pollard AJ. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis 2005 5 : 21 30.
9. Gray SJ, Trotter CL, Ramsay ME, Guiver M, Fox AJ, Borrow R, Mallard RH, Kaczmarski EB. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol 2006 55 : 887 96.
10. Edwards EA, Devine LF, Sengbusch GH, Ward HW. Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand J Infect Dis 1977 9 : 105 10.
11. Crotty S, Ahmed R. Immunological memory in humans. Semin Immunol 2004 16 : 197 203.
12. Slifka MK, Ahmed R. Long-term antibody production is sustained by antibody-secreting cells in the bone marrow following acute viral infection. Ann N Y Acad Sci 1996 797 : 166 76.
13. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998 8 : 363 72.
14. McHeyzer-Williams LJ, McHeyzer-Williams M. Antigen-specific memory B cell development. Annu Rev Immunol 2005 23 : 487 513.
15. Pihlgren M, Schallert N, Tougne C et al. Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life. Eur J Immunol 2001 31 : 939 46.
16. Pihlgren M, Friedli M, Tougne C, Rochat AF, Lambert PH, Siegrist CA. Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. J Immunol 2006 176 : 165 72.
17. Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, Bodman-Smith M, Webster AD. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 2003 48 : 2146 54.
18. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004 350 : 2572 81.
19. Rohner GB, Snape MD, Kelly DF et al. The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response. J Immunol 2008 180 : 2165 73.
20. Gheesling LL, Carlone GM, Pais LB et al. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol 1994 32 : 1475 82.
21. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002 298 : 2199 202.
22. Brinkman DM, Jol-van der Zijde CM, ten Dam MM, Vossen JM, Osterhaus AD, Kroon FP, van Tol MJ. Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man. J Clin Immunol 2003 23 : 528 38.
23. Curtis JE, Hersh EM, Harris JE, McBride C, Freireich EJ. The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation. Clin Exp Immunol 1970 6 : 473 91.
24. Weits J, de Gast GC, The TH, Esselink MT, Deelder AM, Petrovic M, Mandema E. Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol 1978 32 : 443 50.
25. Smith KG, Hewitson TD, Nossal GJ, Tarlinton DM. The phenotype and fate of the antibody-forming cells of the splenic foci. Eur J Immunol 1996 26 : 444 8.
26. Takahashi Y, Dutta PR, Cerasoli DM, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. J Exp Med 1998 187 : 885 95.
27. Crotty S, Kersh EN, Cannons J, Schwartzberg PL, Ahmed R. SAP is required for generating long-term humoral immunity. Nature 2003 421 : 282 7.
28. Slifka MK, Matloubian M, Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 1995 69 : 1895 902.
29. Thiele CJ, Stevens RH. Expression of surface membrane IgG on pokeweed mitogen-reactive anti-tetanus toxoid antibody-producing cells. J Clin Immunol 1981 1 : 174 80.
30. Gonzalez-Garcia I, Ocana E, Jimenez-Gomez G, Campos-Caro A, Brieva JA. Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells. J Immunol 2006 176 : 4042 50.
31. Kehrl JH, Fauci AS. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. J Clin Invest 1983 71 : 1032 40.
32. Stevens RH, Macy E, Morrow C, Saxon A. Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol 1979 122 : 2498 504.
33. Geha RS. Dynamics of human circulating antigen reactive cells following secondary immunization with tetanus toxoid. Clin Immunol Immunopathol 1981 19 : 196 205.
34. Kodo H, Gale RP, Saxon A. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans. J Clin Invest 1984 73 : 1377 84.
35. Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I, Brieva JA. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 2002 99 : 2154 61.
36. Odendahl M, Mei H, Hoyer BF et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005 105 : 1614 21.
37. Blink EJ, Light A, Kallies A, Nutt SL, Hodgkin PD, Tarlinton DM. Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med 2005 201 : 545 54.
38. Baine Y, Thorbecke GJ. Induction and persistence of local B cell memory in mice. J Immunol 1982 128 : 639 43.
39. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004 286 : 111 22.
40. Minges Wols HA, Underhill GH, Kansas GS, Witte PL. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J Immunol 2002 169 : 4213 21.
41. Kelly DF, Snape MD, Cutterbuck EA et al. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood 2006 108 : 2642 7.
42. Nanan R, Heinrich D, Frosch M, Kreth HW. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine 2001 20 : 498 504.
43. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991 21 : 2951 62.
44. MacLennan IC. Germinal centers. Annu Rev Immunol 1994 12 : 117 39.
45. Jacquot S, Kobata T, Iwata S, Morimoto C, Schlossman SF. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J Immunol 1997 159 : 2652 7.
46. Traggiai E, Puzone R, Lanzavecchia A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 2003 21 (Suppl 2 S35 7.
47. Borrow R, Goldblatt D, Finn A et al. Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom. Infect Immun 2003 71 : 5549 55.
48. Snape M, Kelly DF, Diggle L, Lewis S, Banner C, Schulze V, Borkowski X, Pollard AJ A Sustained Increase in Meningococcal Serogroup C Specific IgG Following Glycoconjugate or Plain Polysaccharide Meningococcal Vaccines in Adolescents Previously Immunised With Serogroup C Meningococcal Glycoconjugate Vaccine. Carins, Australia : International Pathogenic Neisseria Conference, 2006.
49. Vu DM, Welsch JA, Zuno-Mitchell P, Dela Cruz JV, Granoff DM. Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine. J Infect Dis 2006 193 : 821 8.
50. Lanzavecchia A, Bernasconi N, Traggiai E, Ruprecht CR, Corti D, Sallusto F. Understanding and making use of human memory B cells. Immunol Rev 2006 211 : 303 9.
51. Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997 388 : 133 4.
52. Ahuja A, Anderson SM, Khalil A, Shlomchik MJ. Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci USA 2008 105 : 4802 7.
53. Snape MD, Kelly DF, Salt P et al. Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization. Clin Infect Dis 2006 43 : 1387 94.
54. Ridderstad A, Nossal GJ, Tarlinton DM. The xid mutation diminishes memory B cell generation but does not affect somatic hypermutation and selection. J Immunol 1996 157 : 3357 65.
55. Vora KA, Tumas-Brundage K, Manser T. Contrasting the in situ behavior of a memory B cell clone during primary and secondary immune responses. J Immunol 1999 163 : 4315 27.